NCT00516386View on ClinicalTrials.gov

Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

December 31, 2008

Conditions

Anorexia Nervosa

Interventions

DRUG

RhIGF-1

35-40 mcg/k/dose twice daily SC

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Tercica

INDUSTRY

lead

Massachusetts General Hospital

OTHER